ResearcherBeckman Research InstituteActive in the last 2 years
Zhifang Zhang
Matched on ORCID iD 0000-0002-1047-2402; OpenAlex author ID A5065940864. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2020: 1 paper · 2021: none · 2022: 3 papers · 2023: none · 2024: none · 2025: 1 paper
Papers 5
- CF33-hNIS-antiPDL1 enhances immunogenicity and anti-tumor efficacy in an orthotopic syngeneic pancreatic cancer mouse model. Co-author DOI 10.1016/j.biopha.2025.118408↗
- PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-a… Co-author DOI 10.1016/j.omto.2021.12.022↗
- Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer. Co-author DOI 10.1016/j.omto.2022.02.022↗
- CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. Co-author DOI 10.1038/s41417-021-00350-4↗
- Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer. First author DOI 10.1016/j.jamcollsurg.2019.12.027↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yanghee Woo · 5 shared papers, 2020–2025 · strength 0.77
- Paper CF33-hNIS-antiPDL1 enhances immunogenicity and anti-tumor efficacy in an orthotopic syngeneic pancreatic cancer mouse m… DOI 10.1016/j.biopha.2025.118408↗
- Paper PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration… DOI 10.1016/j.omto.2021.12.022↗
- Paper CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. DOI 10.1038/s41417-021-00350-4↗
- Yuman Fong · 5 shared papers, 2020–2025 · strength 0.77
- Paper CF33-hNIS-antiPDL1 enhances immunogenicity and anti-tumor efficacy in an orthotopic syngeneic pancreatic cancer mouse m… DOI 10.1016/j.biopha.2025.118408↗
- Paper PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration… DOI 10.1016/j.omto.2021.12.022↗
- Paper CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. DOI 10.1038/s41417-021-00350-4↗
- Sang‐In Kim · 5 shared papers, 2020–2025 · strength 0.77
- Paper CF33-hNIS-antiPDL1 enhances immunogenicity and anti-tumor efficacy in an orthotopic syngeneic pancreatic cancer mouse m… DOI 10.1016/j.biopha.2025.118408↗
- Paper PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration… DOI 10.1016/j.omto.2021.12.022↗
- Paper CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. DOI 10.1038/s41417-021-00350-4↗
- Susanne Gray Warner · 4 shared papers, 2020–2022 · strength 0.53
- Paper PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration… DOI 10.1016/j.omto.2021.12.022↗
- Paper CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. DOI 10.1038/s41417-021-00350-4↗
- Paper Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer. DOI 10.1016/j.omto.2022.02.022↗
- Daniel D. Von Hoff · 2 shared papers, 2020–2022 · strength 0.25
- Courtney Chen · 1 shared paper, 2025 · strength 0.24
- Haiyong Han · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.